| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/13/2011 | CN102008509A Maixuekang enteric coated tablets and preparation method thereof |
| 04/13/2011 | CN102008500A Medicinal external emulsifiable paste for relieving pain and itching and subsiding swelling |
| 04/13/2011 | CN102008479A Cefaclor/montmorillonite composite material and preparation method thereof |
| 04/13/2011 | CN102008477A Method for preparing tablet drug composition containing Rosuvastatin calcium |
| 04/13/2011 | CN102008476A Hydroxypropyl-beta-cyclodextrin inclusion of strychnine and preparation method thereof |
| 04/13/2011 | CN102008466A Febuxostat medicament composition and preparation method thereof |
| 04/13/2011 | CN102008462A 酮洛芬缓释制剂 Ketoprofen sustained-release preparations |
| 04/13/2011 | CN102008461A Ibuprofen drug composite for injection |
| 04/13/2011 | CN102008458A Water resistant patch preparation |
| 04/13/2011 | CN102008456A Novel skeleton sustained release tablet containing metoprolol succinate |
| 04/13/2011 | CN102008455A Freeze-dried powder preparation for curing bovine mastitis |
| 04/13/2011 | CN102008454A Daidzein-entrapped PLGA nanoparticles and preparation method thereof |
| 04/13/2011 | CN102008451A Method for preparing adhesive pellets by extrusion and spheronization |
| 04/13/2011 | CN102008450A Drug-cyclodextrin nanoparticles and preparation method thereof |
| 04/13/2011 | CN102008449A Lansoprazole enteric pellet and preparation method thereof |
| 04/13/2011 | CN102008448A Metadoxine granules and preparation and quality control method thereof |
| 04/13/2011 | CN102008447A Entecavir solid dispersion and preparation thereof |
| 04/13/2011 | CN102008446A 吡非尼酮固体分散体及其制剂 Pirfenidone solid dispersion and its preparations |
| 04/13/2011 | CN102008445A Amoxicillin soluble powder as well as preparation method and application thereof |
| 04/13/2011 | CN102008444A Preparation method of mitoxantrone-loaded dextran-polylactic acid copolymer nano particles |
| 04/13/2011 | CN102008443A 4-amino-2-trifluoromethyl-phenylretinate solid dispersion and preparation method thereof |
| 04/13/2011 | CN102008441A Endoglin antibody coupled liposome as well as preparation method and application thereof |
| 04/13/2011 | CN102008440A Solid preparation of atorvastatin calcium liposome |
| 04/13/2011 | CN102008439A Curcumin coated liposome preparation and preparation method thereof |
| 04/13/2011 | CN102008438A Cis-platinum lung cancer-resistant active targeting stealth liposomes and preparation method thereof |
| 04/13/2011 | CN102008436A Nocathiacin antibiotic medicament composition containing emulsifying agent |
| 04/13/2011 | CN102008434A Compound docetaxel ester microsphere injection and preparation method thereof |
| 04/13/2011 | CN102008433A Fasudil salt injection for improving stability and preparation method thereof |
| 04/13/2011 | CN102008432A Sodium demethylcantharidate medicinal composition for injection and preparation method thereof |
| 04/13/2011 | CN102008431A Double-layer moxifloxacin suppository and preparation method thereof |
| 04/13/2011 | CN102008429A Tacrolimus controlled release preparation and preparation method thereof |
| 04/13/2011 | CN102008428A Ophthalmic depot formulations for periocular or subconjunctival administration |
| 04/13/2011 | CN102008427A Latanoprost ophthalmic in situ slow release gel |
| 04/13/2011 | CN102008000A Breath freshening and oral cleansing product with magnolia bark extract |
| 04/13/2011 | CN101708174B Plant hollow capsule, soft capsule composition and preparation methods thereof |
| 04/13/2011 | CN101658491B Amnion eye drops for curing cornea alkali burn |
| 04/13/2011 | CN101653498B Nano-herb micro-pills for removing eel poisoning and preparation method thereof |
| 04/13/2011 | CN101627968B Preparation method of alprostadil injection |
| 04/13/2011 | CN101596171B Tamsulosin sustained release tablet and preparation method thereof |
| 04/13/2011 | CN101507741B Red beet extract and composition and preparation method and medicine for restraining tumor growth |
| 04/13/2011 | CN101485646B Andrographolide catablasm and preparation method thereof |
| 04/13/2011 | CN101454007B Adhesive |
| 04/13/2011 | CN101450117B Rheumatism treatment medicine composition, formulation and preparation method |
| 04/13/2011 | CN101380340B Wall-broken glossy ganoderma spore powder antioxidation method |
| 04/13/2011 | CN101365433B Iontophoresis preparation |
| 04/13/2011 | CN101306134B Compound Nanxing pain paste and cataplasm combination and its preparation method |
| 04/13/2011 | CN101288680B Preparation method of instant tuckahoe granule |
| 04/13/2011 | CN101278948B Biological medical membrane and method of preparing the same |
| 04/13/2011 | CN101254235B Method of preparing extract for curing periodontal diseases |
| 04/13/2011 | CN101212960B Eye drop preparation comprising xanthan gum and terpenoid |
| 04/13/2011 | CN101199857B Combination of mPEG-PLA-tree alkali medicament |
| 04/13/2011 | CN101199548B Perfluorination carbon emulsion and preparing method thereof |
| 04/13/2011 | CN101146516B Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 04/13/2011 | CN101057966B Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor |
| 04/13/2011 | CN101028264B Huisanliu tablets as medicine and their preparation |
| 04/12/2011 | US7923560 Delivery of immune response modifier compounds |
| 04/12/2011 | US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 04/12/2011 | US7923547 for antisense therapy |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923536 Compositions and methods of delivery of pharmacological agents |
| 04/12/2011 | US7923509 Drug delivery compositions and medical devices containing block copolymer |
| 04/12/2011 | US7923469 Compositions including vitamin-based surfactants and methods for using same |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923431 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 04/12/2011 | US7923230 Neurodegenerative protein aggregation inhibition methods and compounds |
| 04/12/2011 | US7923216 In vivo modulation of neuronal transport |
| 04/12/2011 | US7923042 Medicated gauze |
| 04/12/2011 | US7923041 Compositions and methods for enhancing cognitive function |
| 04/12/2011 | US7923034 Process for producing microparticles |
| 04/12/2011 | US7923032 polymer compositions of the invention are biodegradable, non-toxic, and provide sustained delivery of therapeutic agents at an area of interest within the central nervous system |
| 04/12/2011 | US7923030 Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
| 04/12/2011 | US7923025 Pharmaceutical composition for oral use with improved absorption |
| 04/12/2011 | US7923024 Mineral composition |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | CA2526771C Synthesis of high molecular weight iron-saccharidic complexes |
| 04/12/2011 | CA2462905C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 04/12/2011 | CA2460867C Nanoparticulate insulin formulations |
| 04/12/2011 | CA2452813C Unimolecular polymeric micelles with an ionizable inner core |
| 04/12/2011 | CA2446221C Stable powder inhalation dosage formulation |
| 04/12/2011 | CA2434060C Preparation of a therapeutic composition |
| 04/12/2011 | CA2414241C Polymeric micelle compositions |
| 04/12/2011 | CA2362299C Sheet-form adhesive preparation |
| 04/12/2011 | CA2185644C Use of green porphyrins in ocular diagnosis and therapy |
| 04/07/2011 | WO2011041680A2 Compositions and methods of prophylaxis for contact dermatitis |
| 04/07/2011 | WO2011041609A2 Topical formulations |
| 04/07/2011 | WO2011041542A2 Herbal pain killer compositions |
| 04/07/2011 | WO2011041300A1 Reduced-odor polyol composition and method of producing same |
| 04/07/2011 | WO2011040973A2 Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof |
| 04/07/2011 | WO2011040969A1 Compositions and methods for the treatment of atherosclerosis and other related diseases |
| 04/07/2011 | WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 04/07/2011 | WO2011040572A1 Ophthalmic composition |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040433A1 Eye drops |
| 04/07/2011 | WO2011040432A1 Eye wash agent |
| 04/07/2011 | WO2011040195A1 Unpleasant taste-masking particles and an oral preparation containing same |
| 04/07/2011 | WO2011040141A1 Composition containing fat-soluble vitamin |
| 04/07/2011 | WO2011040013A1 Novel liquid crystal composition |
| 04/07/2011 | WO2011039952A1 Method for improving the aqueous solubility of poorly-soluble substances |
| 04/07/2011 | WO2011039724A1 Antibodies that specifically bind to the epha2 receptor |
| 04/07/2011 | WO2011039511A2 Agents, uses and methods |